A human monoclonal antibody blocking SARS-CoV-2 infection
Fecha
2020-05-04Autor
Wang, Chunyan
Li, Wentao
Drabek, Dubravka
Okba, Nisreen M.A.
van Haperen, Rien
Osterhaus, Albert D.M.E.
van Kuppeveld, Frank J.M.
Haagmans, Bart L.
Grosveld, Frank
Bosch, Berend Jan
Documentos PDF
Resumen en idioma extranjero
The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV) in cell culture. This cross-neutralizing antibody targets a communal epitope on these viruses and may offer potential for prevention and treatment of COVID-19.
Palabras clave
AnticuerposEnlace al recurso
https://www.nature.com/articles/s41467-020-16256-yColecciones
Estadísticas Google Analytics
Comentarios
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.